Results 31 to 40 of about 40,797 (259)

Consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID‐19–related illness

Journal of Thrombosis and Haemostasis, 2020
Observational studies indicate that children hospitalized with COVID‐19‐related illness, like adults, are at increased risk for venous thromboembolism (VTE).
N. Goldenberg, A. Sochet, M. Albisetti, T. Biss, M. Bonduel, J. Jaffray, G. MacLaren, P. Monagle, S. O’Brien, L. Raffini, S. Revel-Vilk, N. Sirachainan, Suzan Williams, A. Zia, C. Male   +14 more
semanticscholar   +1 more source

Real-practice thromboprophylaxis in atrial fibrillation [PDF]

, 2017
This retrospective observational study was based on databases of the Local Health Authority of Treviso, Italy. It evaluated the prevalence and the effectiveness of oral anticoagulation treatment (OAT) for the management of nonvalvular atrial fibrillation
Bettiol, Alessandra, Bolcato, Jenny, Chinellato, Alessandro, Deambrosis, Paola, Franchin, Giulia, Giusti, Pietro, Pellizzari, Michele, Pirolo, Roberta, Themistoclakis, Sakis   +8 more
core   +2 more sources

Rivaroxaban for Thromboprophylaxis in High‐Risk Ambulatory Patients with Cancer

New England Journal of Medicine, 2019
BACKGROUND Ambulatory patients receiving systemic cancer therapy are at varying risk for venous thromboembolism. However, the benefit of thromboprophylaxis in these patients is uncertain. METHODS In this double‐blind, randomized trial involving high‐risk
A. Khorana, G. Soff, A. Kakkar, S. Vadhan-Raj, H. Riess, T. Wun, M. Streiff, D. Garcia, H. Liebman, C. Belani, E. O’Reilly, J. Patel, Habte A. Yimer, P. Wildgoose, P. Burton, U. Vijapurkar, Simrati Kaul, J. Eikelboom, R. McBane, K. Bauer, N. Kuderer, G. Lyman   +21 more
semanticscholar   +1 more source

THROMBOPROPHYLAXIS;

The Professional Medical Journal, 2012
Maternal obesity (body mass index, BMI≥30kg/m²) is a global health problem. Significant evidence is available that it is directlyassociated with an increased risk of venous thromboembolic events in pregnancy and puerperium. Objective: This study aims to assess ourcurrent management protocols for thromboprophylaxis and to improve them according to ...
NAUSHEEN NABEEL, FAUZIA FAHIM, TALHA ABDUL HALIM   +2 more
openaire   +2 more sources

How we treat bleeding associated with direct oral anticoagulants [PDF]

, 2016
Direct oral anticoagulants are at least as effective as vitamin K antagonists for the prevention and treatment of thromboembolism. Unfortunately, differently from vitamin K antagonists, they have the great drawback of lacking specific antidotes in the ...
Franchini, Massimo, Liumbruno, Giancarlo M, Marano, Giuseppe, Pupella, Simonetta, VAGLIO, Stefania   +4 more
core   +1 more source

Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH

Journal of Thrombosis and Haemostasis, 2022
Hospital‐associated venous thromboembolism (HA‐VTE) is a major cause of morbidity and mortality and is internationally recognized as a significant patient safety issue.
L. Roberts, V. Hernández-Gea, M. Magnusson, S. Stanworth, J. Thachil, A. Tripodi, T. Lisman   +6 more
semanticscholar   +1 more source

Hematologists’ awareness of venous thromboembolism in multiple myeloma: a national survey in China

Annals of Medicine, 2023
Background Venous thromboembolism (VTE) is one of the most common and severe complications of multiple myeloma (MM). The aim of this study was to learn about the current awareness regarding MM-associated VTE among Chinese hematologists.Methods A ...
Qun Li, Bo Zhang, Qianwen Cheng, Fei Zhao, Junying Li, Han Yan, Aoshuang Xu, Chunyan Sun, Yu Hu   +8 more
doaj   +1 more source

Extended thromboprophylaxis with betrixaban in acutely ill medical patients [PDF]

, 2016
BACKGROUND: Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown.
. Lodigiani, M, : W. Ageno, I, Cerveri, A., Cohen, Alexander T, De Pellegrin, D, D’Angelo, A, Gibson, C. Michael, Gold, Alex, Goldhaber, Samuel Z., Harrington, Robert A., Hernandez, Adrian F., Hull, Russell D., Imberti, R., Investigators, Italy (261 patients, 19 sites, Landolfi, G, LEMBO, Giuseppe, Luisetti, M., Wiens, Brian L.   +18 more
core   +1 more source

Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials

Journal of Clinical Medicine, 2022
Coronavirus disease 2019 (COVID-19) has been shown to be strongly associated with increased risk for venous thromboembolism events (VTE) mainly in the inpatient but also in the outpatient setting.
K. Kyriakoulis, E. Dimakakos, Ioannis G. Kyriakoulis, M. Catalano, A. Spyropoulos, S. Schulman, J. Douketis, A. Falanga, A. Maraveyas, D. Olinic, J. Belch, G. Gerotziafas, K. Syrigos, A. Kollias, Covid-Thrombosis Collaborative Group Endorsed By V   +14 more
semanticscholar   +1 more source

Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection

Thrombosis Update, 2021
Background: Patients with severe SARS-CoV-2 infection have been shown to have abnormal coagulation parameters and are at increased risk of thromboembolism. The optimal thromboprophylaxis regimen that minimizes thrombosis without increased risk of serious
R.L. Kummer, K.A. Considine, M.A. Rankin, L.M. Hubbard, T.S. Lam, L.T. Thornton, A.R. Lindsay, A.S. Ahiskali, J.W. Leatherman   +8 more
doaj   +1 more source